Marco Bolis

15PUBLICATIONS
149CO-AUTHORS
Molecular targetsCancer cell biologyPredictive and prognostic markersRegenerative medicine (incl. stem cells)Medical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jan 14, 2026
A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules.

Phillip Thienger, Irene Paassen, Xiaosai Yao

|Sep 02, 2025
Integrated control of cancer stemness by σ1 receptor in advanced prostate cancer.

Gianluca Civenni, Giada Sandrini, Jessica Merulla

|Jul 30, 2025
Tumor-associated neutrophil precursors impair homologous DNA repair and promote sensitivity to PARP inhibition.

Siddhartha Mukherjee, Cindy Garda, Letizia Boffa

|Jun 19, 2025
Mesenchymal Stromal Cell Secretome and Its Key Bioactive Metabolites Induce Long-Term Neuroprotection After Traumatic Brain Injury in Mice.

Francesca Pischiutta, Francesca Tribuzio, Marta Magatti

|Feb 23, 2025
Increased ectodysplasin-A2-receptor EDA2R is a ubiquitous hallmark of aging and mediates parainflammatory responses.

Maria Chiara Barbera, Luca Guarrera, Andrea David Re Cecconi

|Jan 25, 2025
Onvansertib and Navitoclax Combination as a New Therapeutic Option for Mucinous Ovarian Carcinoma.

Serena Petrella, Marika Colombo, Mirko Marabese

Pageof 3